TGFB1 anticorps (AA 336-385)
Aperçu rapide pour TGFB1 anticorps (AA 336-385) (ABIN1533412)
Antigène
Voir toutes TGFB1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 336-385
-
Specificité
-
TGF beta1 Antibody detects endogenous levels of total TGF beta1 protein.
-
Purification
- The antibody was purified from rabbit antiserum by affinity-chromatography using immunogen.
-
Pureté
- > 95 %
-
Immunogène
- The antiserum was produced against synthesized peptide derived from human TGF beta1.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:5000
-
Commentaires
-
Unigene-Number: Hs.645227 (NCBI Gene Symbol: TGFB1)
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Stable at -20°C for at least 1 year.
-
Date de péremption
- 12 months
-
-
-
: "Characterization of fibrosis-promoting factors and siRNA-mediated therapies in C-protein-induced experimental autoimmune myocarditis." dans: Cellular immunology, Vol. 279, Issue 1, pp. 70-7, (2012) (PubMed).
-
: "Characterization of fibrosis-promoting factors and siRNA-mediated therapies in C-protein-induced experimental autoimmune myocarditis." dans: Cellular immunology, Vol. 279, Issue 1, pp. 70-7, (2012) (PubMed).
-
- TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))
-
Autre désignation
- TGF Beta1
-
Sujet
-
Synonyms: CED, diaphyseal dysplasia 1, progressive, DPD1, TGF-beta 1, TGFB, transforming growth factor, beta 1, transforming growth factor, beta 1 (Camurati-Engelmann disease)
NCBI Gene Symbol: TGFB1
-
Poids moléculaire
- 44 kDa
-
ID gène
- 7040
-
OMIM
- 131300
-
UniProt
- P01137
-
Pathways
- EGFR Signaling Pathway, Dopaminergic Neurogenesis, Cellular Response to Molecule of Bacterial Origin, Glycosaminoglycan Metabolic Process, Regulation of Leukocyte Mediated Immunity, Regulation of Muscle Cell Differentiation, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Production of Molecular Mediator of Immune Response, Ribonucleoside Biosynthetic Process, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Protein targeting to Nucleus, Autophagy, Cancer Immune Checkpoints
Antigène
-